Table 4.

Multivariable^a-adjusted HRs and 95% CI for the association between dietary PUFA intake and breast cancer-specific mortality among a population-based sample of women with breast cancer (N=1,463), LIBCSP, 1996/1997 through 2011(an average of 14.7 years of follow-up)

PUFA	Q1		Q2			Q3			Q4			p for linear trend
	D	HR	D	HR	95% CI	D	HR	95% CI	D	HR	95% CI
Total PUFA	38	1.00	62	1.56	1.03, 2.36	53	1.25	0.80, 1.95	57	1.25	0.74, 2.11	0.63
Total ω-3	43	1.00	51	1.08	0.71, 1.64	63	1.32	0.87, 2.01	53	0.96	0.57, 1.61	0.80
ALA	46	1.00	50	1.06	0.71, 1.60	57	1.17	0.77, 1.77	57	1.03	0.64, 1.68	0.64
DPA	55	1.00	50	0.85	0.58, 1.25	44	0.69	0.46, 1.03	61	0.93	0.63, 1.38	0.52
DHA	55	1.00	50	0.88	0.58, 1.25	50	0.81	0.55, 1.19	55	0.86	0.59, 1.27	0.53
EPA	53	1.00	50	0.92	0.62, 1.35	51	0.84	0.57, 1.25	56	0.92	0.63, 1.36	0.57
Total ω-6	37	1.00	61	1.59	1.05, 2.42	54	1.34	0.86, 2.11	58	1.36	0.81, 2.30	0.62
LA	37	1.00	61	1.60	1.05, 2.43	54	1.35	0.86, 2.11	58	1.36	0.81, 2.29	0.63
AA	47	1.00	48	0.98	0.65, 1.47	52	1.01	0.67, 1.52	63	1.22	0.80, 1.86	0.40
ω-3/ω-6	63	1.00	44	0.65	0.44, 0.95	53	0.79	0.55, 1.15	50	0.79	0.54, 1.14	0.13

Note:

D=deaths, LIBCSP=Long Island Breast Cancer Study Project

^aMultivariable-adjusted HRs and 95% CI adjusted age (5-year age group) and total energy intake (kcal/day)